Clinical Trial Update: RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke

View source ↗

Summary

Clinical trial update on rivaroxaban for reducing recurrent embolism in patients with acute ischemic stroke associated with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Japan Cardiovascular Research Foundation | Conditions: Stroke, Acute, Atrial Fibrillation | Status: UNKNOWN